Literature DB >> 18210978

Granulomatous meningoencephalomyelitis in dogs.

P Filippo Adamo1, William M Adams, Howard Steinberg.   

Abstract

Granulomatous meningoencephalomyelitis (GME) is a nonsuppurative inflammatory disease of unknown origin that affects the central nervous system of dogs. GME is characterized histologically by large perivascular cuffs of mononuclear cells in the parenchyma and meninges of the brain and spinal cord. If left untreated, it is usually fatal. Immunosuppressive doses of glucocorticosteroids have been the mainstay of treatment for GME; however, new and more effective therapies have recently been proposed. This article reviews the pathology, origin, clinical signs, therapeutic response, and outcome of GME in dogs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18210978

Source DB:  PubMed          Journal:  Compend Contin Educ Vet        ISSN: 1940-8307


  4 in total

1.  Correlation between fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of non-suppurative meningoencephalitis in 5 dogs.

Authors:  Byeong-Teck Kang; Seung-Gon Kim; Chae-Young Lim; Su-Hyun Gu; Dong-Pyo Jang; Young-Bo Kim; Dae-Young Kim; Eung-Je Woo; Zang-Hee Cho; Hee-Myung Park
Journal:  Can Vet J       Date:  2010-09       Impact factor: 1.008

2.  A study of experimental autoimmune encephalomyelitis in dogs as a disease model for canine necrotizing encephalitis.

Authors:  Jong-Hyun Moon; Hae-Won Jung; Hee-Chun Lee; Joon-Hyeok Jeon; Na-Hyun Kim; Jung-Hyang Sur; Jeongim Ha; Dong-In Jung
Journal:  J Vet Sci       Date:  2014-09-30       Impact factor: 1.672

Review 3.  Oral cyclosporine treatment in dogs: a review of the literature.

Authors:  T M Archer; D M Boothe; V C Langston; C L Fellman; K V Lunsford; A J Mackin
Journal:  J Vet Intern Med       Date:  2013-12-16       Impact factor: 3.333

4.  Epidemiology of necrotizing meningoencephalitis in Pug dogs.

Authors:  J M Levine; G T Fosgate; B Porter; S J Schatzberg; K Greer
Journal:  J Vet Intern Med       Date:  2008 Jul-Aug       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.